IPO Trending
TATVAEQ / NSE, BSEListed
Tatva Chintan Pharma Chem

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a specialty chemical manufacturer engaged in producing structure directing agents, phase transfer catalysts, pharmaceutical and agrochemical intermediates, and other specialty chemicals, and is among the largest producers of SDAs for zeolites in India. The company caters to a wide range of industries including automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceuticals, personal care, and others, with products sold in India and exported to over 25 countries such as the USA, Germany, South Africa, China, and the UK. Exports contributed around 76% of its revenue in FY 2020, and its customer base includes leading names like Merck, Bayer AG, Laurus Labs, Navin Fluorine, Atul Limited, SRF Limited, and Divi’s Laboratories, with manufacturing facilities located at Ankleshwar and Dahej in Gujarat.

₹1,073 - ₹1,083Open
Listed Price₹2111.85
Listing Gain+95.00%

Subscription Status

0Updated 20 Oct 2026, 01:30 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date16 Jul 2021
Close Date20 Jul 2021
Listing Date29 Jul 2021
Bidding status cross-verified with live IPO subscription numbers ↗BSE & NSE Bidding Portal Feed

About Tatva Chintan Pharma Chem IPO Subscription Demand

Live subscription status and bidding analysis for Tatva Chintan Pharma Chem (TATVA) IPO. The issue is subscribed Tracking Live overall across Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII/HNI), and Retail Individual Investors (RII). Check real-time grey market demand on our GMP Tracker or review full issue details, lot size, and price band on the IPO Details Page.

Frequently Asked Questions